Practical management of opioid rotation and equianalgesia

References

• MercadanteSBrueraEOpioid switching in cancer pain: From the beginning to nowadaysCrit Rev Oncol Hematol20169924124826806145
   PubMed Web of Science ®Google Scholar
• LawlorPGBrueraESide-effects of opioids in chronic pain treatmentCurr Opin Anaesthesiol199811553954517013271
   PubMedGoogle Scholar
• WaltersJBMontagniniMCurrent concepts in the management of opioid-induced constipationJ Opioid Manag20106643544421269005
   PubMedGoogle Scholar
• ReimerKHoppMZenzMMeeting the challenges of opioid-induced constipation in chronic pain management - a novel approachPharmacology2009831101718957874
   PubMed Web of Science ®Google Scholar
• MccannSYakshTLvon GuntenCFCorrelation between myoclonus and the 3-glucuronide metabolites in patients treated with morphine or hydromorphone: A pilot studyJ Opioid Manag201062879420481173
   PubMedGoogle Scholar
• de SchepperHUCremoniniFParkMICamilleriMOpioids and the gut: pharmacology and current clinical experienceNeurogastroenterol Motil200416438339415305992
   PubMed Web of Science ®Google Scholar
• InturrisiCEClinical pharmacology of opioids for painClin J Pain200218SupplementS3S1312479250
   PubMed Web of Science ®Google Scholar
• FinePGPortenoyRKEstablishing “Best Practices” for opioid rotation: conclusions of an expert panelJ Pain Symptom Manage200938341842519735902
   PubMed Web of Science ®Google Scholar
• KuritaGPLundorffLPimentaCASjøgrenPThe cognitive effects of opioids in cancer: a systematic reviewSupport Care Cancer2009171112118762994
   PubMed Web of Science ®Google Scholar
• MercadanteSBrueraEOpioid switching: A systematic and critical reviewCancer Treat Rev200632430431516624490
   PubMed Web of Science ®Google Scholar
• SilvermanSMOpioid induced hyperalgesia: clinical implications for the pain practitionerPain Physician200912367968419461836
   PubMed Web of Science ®Google Scholar
• MitraSOpioid-induced hyperalgesia: pathophysiology and clinical implicationsJ Opioid Manag20084312313018717507
   PubMedGoogle Scholar
• Müller-BuschHCLindenaGTietzeKWoskanjanSOpioid switch in palliative care, opioid choice by clinical need and opioid availabilityEur J Pain20059557157916139186
   PubMed Web of Science ®Google Scholar
• de Leon-CasasolaOACurrent developments in opioid therapy for management of cancer painClin J Pain200824Supplement 10S3S718418225
   PubMed Web of Science ®Google Scholar
• MercadanteSOpioid rotation for cancer pain: rationale and clinical aspectsCancer19998691856186610547561
   PubMed Web of Science ®Google Scholar
• ChernyNJChangVFragerGOpioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administrationCancer1995767128312938630910
   PubMed Web of Science ®Google Scholar
• LevyMHPharmacologic treatment of cancer painN Engl J Med Overseas Ed19963351511241132
   PubMed Web of Science ®Google Scholar
• MaddocksISomogyiAAbbottFHayballPParkerDAttenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodoneJ Pain Symptom Manage19961231821898803381
   PubMed Web of Science ®Google Scholar
• MercadanteSFerreraPVillariPCasuccioAIntravaiaGMangioneSFrequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unitJ Pain Symptom Manage200937463264119345298
   PubMed Web of Science ®Google Scholar
• RipamontiCDickersonEDStrategies for the treatment of cancer pain in the new millenniumDrugs200161795597711434451
   PubMed Web of Science ®Google Scholar
• SmithHSVariations in opioid responsivenessPain Physician200811223724818354715
   PubMed Web of Science ®Google Scholar
• SlatkinNEOpioid switching and rotation in primary care: implementation and clinical utilityCurr Med Res Opin20092592133215019601703
   PubMed Web of Science ®Google Scholar
• MillerKDSiegelRLLinCCCancer treatment and survivorship statistics, 2016CA Cancer J Clin201666427128927253694
   PubMed Web of Science ®Google Scholar
• KnotkovaHFinePGPortenoyRKOpioid rotation: the science and the limitations of the equianalgesic dose tableJ Pain Symptom Manage200938342643919735903
   PubMed Web of Science ®Google Scholar
• BerdineHJNesbitSAEquianalgesic dosing of opioidsJ Pain Palliat Care Pharmacother20062047984
   PubMedGoogle Scholar
• DavisMPCancer painOlverINThe MASCC Textbook of Cancer Supportive Care and SurvivorshipBoston, MASpringer US20111122
   Google Scholar
• LawlorPTurnerKHansonJBrueraEDose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective studyPain1997721–279859272790
   PubMed Web of Science ®Google Scholar
• QuigleyCOpioid switching to improve pain relief and drug tolerabilityCochrane Database Syst Rev20043CD004847
   Google Scholar
• AndersonRSaiersJHAbramSSchlichtCAccuracy in equi-analgesic dosing. conversion dilemmasJ Pain Symptom Manage200121539740611369161
   PubMed Web of Science ®Google Scholar
• PatanwalaAEDubyJWatersDErstadBLOpioid conversions in acute careAnn Pharmacother200741225526717299011
   PubMed Web of Science ®Google Scholar
• VissersKCPBesseKHansGDevulderJMorlionBOpioid rotation in the management of chronic pain: where is the evidence?Pain Practice2010102859320070552
   PubMed Web of Science ®Google Scholar
• GagnonBBielechMWatanabeSWalkerPHansonJBrueraEThe use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer painSupport Care Cancer19997426527010423053
   PubMed Web of Science ®Google Scholar
• NarabayashiMSaijoYTakenoshitaSOpioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trialJpn J Clin Oncol200838429630418326541
   PubMed Web of Science ®Google Scholar
• BrueraEPereiraJWatanabeSBelzileMKuehnNHansonJOpioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphineCancer19967848528578756381
   PubMed Web of Science ®Google Scholar
• de StoutzNDBrueraESuarez-AlmazorMOpioid rotation for toxicity reduction in terminal cancer patientsJ Pain Symptom Manage19951053783847673770
   PubMed Web of Science ®Google Scholar
• HuntRFazekasBThorneDBrooksbankMA comparison of subcutaneous morphine and fentanyl in hospice cancer patientsJ Pain Symptom Manage199918211111910484858
   PubMed Web of Science ®Google Scholar
• HagenNABabulNComparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer painCancer1997797142814379083166
   PubMed Web of Science ®Google Scholar
• BrueraEBelzileMPituskinERandomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer painJ Clin Oncol19981610322232299779695
   PubMed Web of Science ®Google Scholar
• WirzSWartenbergHCElsenCWittmannMDiederichsMNadstawekJManaging cancer pain and symptoms of outpatients by rotation to sustained-release hydromorphone: a prospective clinical trialClin J Pain200622977077517057558
   PubMed Web of Science ®Google Scholar
• WallaceMRauckRLMoulinDThipphawongJKhannaSTudorICConversion from standard opioid therapy to once-daily oral extended-release hydromorphone in patients with chronic cancer painJ Int Med Res200836234335218380946
   PubMed Web of Science ®Google Scholar
• AhmedzaiSBrooksDTransdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial GroupJ Pain Symptom Manage19971352542619185430
   PubMed Web of Science ®Google Scholar
• MoritaTTakigawaCOnishiHOpioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trialJ Pain Symptom Manage20053019610316043013
   PubMed Web of Science ®Google Scholar
• ClemensKEKlaschikEClinical experience with transdermal and orally administered opioids in palliative care patients-a retrospective studyJpn J Clin Oncol200737430230917519302
   PubMed Web of Science ®Google Scholar
• MercadanteSCaraceniAConversion ratios for opioid switching in the treatment of cancer pain: a systematic reviewPalliat Med201125550451521708857
   PubMed Web of Science ®Google Scholar
• World Health OrganizationCancer Pain Relief: With a Guide to Opioid Availability2nd edGeneva, SwitzerlandWorld Health Organization2009
   Google Scholar
• BabulNProvencherLLabergeFHarsanyiZMoulinDComparative efficacy and safety of controlled-release morphine suppositories and tablets in cancer painJ Clin Pharmacol199838174819597563
   PubMed Web of Science ®Google Scholar
• BrueraEFainsingerRSpachynskiKBabulNHarsanyiZDarkeACClinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluationJ Clin Oncol1995136152015277751901
   PubMed Web of Science ®Google Scholar
• KalsoEVainioAMorphine and oxycodone hydrochloride in the management of cancer painClin Pharmacol Ther19904756396462188774
   PubMed Web of Science ®Google Scholar
• KatoKMizakiTYamazakiSA study of transdermal fentanyl in cancer pain at Aichi-Cancer CenterYakugaku Zasshi2004124528729115118241
   PubMed Web of Science ®Google Scholar
• WatanabeSPereiraJHansonJBrueraEFentanyl by continuous subcutaneous infusion for the management of cancer pain: a retrospective studyJ Pain Symptom Manage19981653233269846027
   PubMed Web of Science ®Google Scholar
• DonnerBZenzMTrybaMStrumpfMDirect conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer painPain19966435275348783318
   PubMed Web of Science ®Google Scholar
• KawanoCHirayamaTKuroyamaMDose conversion in opioid rotation from continuous intravenous infusion of morphine hydrochloride injection to fentanyl patch in the management of cancer painYakugaku Zasshi2011131346346721372544
   PubMed Web of Science ®Google Scholar
• HeiskanenTKalsoEControlled-release oxycodone and morphine in cancer related painPain199773137459414055
   PubMed Web of Science ®Google Scholar
• InoueSSaitoYTsunetoSArugaEOgataTUemoriMA double-blind, randomized comparative study to investigate the morphine to hydromorphone conversion ratio in Japanese cancer patientsJpn J Clin Oncol201848544244929635632
   PubMed Web of Science ®Google Scholar
• ReddyAVidalMStephenSThe conversion ratio from intravenous hydromorphone to oral opioids in cancer patientsJ Pain Symptom Manage201754328028828711751
   PubMed Web of Science ®Google Scholar
• MatsumuraCYamadaMFujiharaSChisakiYTakahashiKYanoYIndication of adequate transdermal fentanyl dose in opioid switching from oral oxycodone in patients with cancerAm J Hosp Palliat Med2016332109114
   Web of Science ®Google Scholar
• ReddyAYennurajalingamSReddySThe opioid rotation ratio from transdermal fentanyl to “Strong” opioids in patients with cancer painJ Pain Symptom Manage20165161040104526826675
   PubMed Web of Science ®Google Scholar
• ReddyATayjasanantSHaiderAThe opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patientsCancer2016122114915626451687
   PubMed Web of Science ®Google Scholar
• KornickCASantiago-PalmaJKhojainovaNPrimaveraLHPayneRManfrediPLA safe and effective method for converting cancer patients from intravenous to transdermal fentanylCancer200192123056306111753984
   PubMed Web of Science ®Google Scholar
• SamalaRVBloiseRDavisMPEfficacy and safety of a six-hour continuous overlap method for converting intravenous to transdermal fentanyl in cancer painJ Pain Symptom Manage201448113213624291296
   PubMed Web of Science ®Google Scholar
• ColuzziFMattiaCOxycodone. Pharmacological profile and clinical data in chronic pain managementMinerva Anestesiol2005717-845146016012419
   PubMedGoogle Scholar
• BeaverWTWallensteinSLRogersAHoudeRWAnalgesic studies of codeine and oxycodone in patients with cancer. I. Comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodoneJ Pharmacol Exp Ther1978207192100359779
   PubMed Web of Science ®Google Scholar
• SarhillNWalshDNelsonKAHydromorphone: pharmacology and clinical applications in cancer patientsSupport Care Cancer200192849611305075
   PubMed Web of Science ®Google Scholar
• ChouRFanciulloGJFinePGClinical guidelines for the use of chronic opioid therapy in chronic noncancer painJ Pain200910211313019187889
   PubMed Web of Science ®Google Scholar
• CaraceniAHanksGKaasaSUse of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPCLancet Oncol2012132e58e6822300860
   PubMed Web of Science ®Google Scholar
• WeschulesDJBainKTRicheimerSActual and potential drug interactions associated with methadonePain Medicine20089331534418386306
   PubMed Web of Science ®Google Scholar
• ZeppetellaGO’DohertyCACollinsSPrevalence and characteristics of breakthrough pain in cancer patients admitted to a hospiceJ Pain Symptom Manage2000202879210989246
   PubMed Web of Science ®Google Scholar
• EddyNBLeeLEJrThe analgesic equivalence to morphine and relative side action liability of oxymorphone (14-hydroxydihydro morphinone)J Pharmacol Exp Ther1959125211612113631610
   PubMed Web of Science ®Google Scholar
• WoodhouseAHobbesAFTMatherLEGibsonMA comparison of morphine, pethidine and fentanyl in the postsurgical patient-controlled analgesia environmentPain19966411151218867253
   PubMed Web of Science ®Google Scholar
• DunbarPJChapmanRCBuckleyPFGavrinJRClinical analgesic equivalence for morphine and hydromorphone with prolonged PCAPain19966822652709121813
   PubMed Web of Science ®Google Scholar
• ReidMCHendersonCRPapaleontiouMCharacteristics of older adults receiving opioids in primary care: treatment duration and outcomesPain Medicine20101171063107120642732
   PubMed Web of Science ®Google Scholar
• BuckleyDICalvertJFLapidusJAMorrisCDChronic opioid therapy and preventive services in rural primary care: an Oregon rural practice-based research network studyAnn Fam Med20108323724420458107
   PubMed Web of Science ®Google Scholar
• VallerandAHHasenauSTemplinTCollins-BohlerDDisparities between black and white patients with cancer pain: the effect of perception of control over painPain Medicine20056324225015972088
   PubMed Web of Science ®Google Scholar
• WoolMSMorVA multidimensional model for understanding cancer painCancer Invest200523872773416377591
   PubMed Web of Science ®Google Scholar
• SyrjalaKLChapkoMEEvidence for a biopsychosocial model of cancer treatment-related painPain199561169797644251
   PubMed Web of Science ®Google Scholar
• KeefeFJAbernethyAPC CampbellLPsychological approaches to understanding and treating disease-related painAnnu Rev Psychol200556160163015709948
   PubMed Web of Science ®Google Scholar
• HanksGWReidCContribution to variability in response to opioidsSupport Care Cancer200513314515215761703
   PubMed Web of Science ®Google Scholar
• JiaSSShangLMeLZhaoDMWhXWangYQModified Glasgow prognostic score predicting high conversion ratio in opioid switching from oral oxycodone to transdermal fentanyl in patients with cancer painInt J Clin Exp Med2015857606761226221306
   PubMed Web of Science ®Google Scholar
• KanbayashiYHosokawaTOkamotoKFactors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer painClin J Pain201127866466721471811
   PubMed Web of Science ®Google Scholar
• PereiraJLawlorPViganoADorganMBrueraEEquianalgesic dose ratios for opioids. a critical review and proposals for long-term dosingJ Pain Symptom Manage200122267268711495714
   PubMed Web of Science ®Google Scholar
• WebsterLRFinePGOverdose deaths demand a new paradigm for opioid rotationPain Med201213457157422458858
   PubMed Web of Science ®Google Scholar